BioSpace News Archive

The U.S. Food and Drug Administration today approved Jatenzo (testosterone undecanoate), an oral testosterone capsule to treat men with certain forms of hypogonadism

Adding momentum to the national campaign to take tobacco out of baseball, the Maricopa County Stadium District Board of Directors today approved a new policy prohibiting the use of smokeless tobacco products (like chew, dip and snuff) at Chase Field, home of the Arizona Diamondbacks

Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced plans to expedite development of avapritinib, BLU-667 and BLU-782 based on recent clinical progress and interactions with regulatory authorities.

ATAI Life Sciences, the global biotech platform dedicated to curing mental health disorders, has completed its series B financing round of $43 million (EUR 38 million).

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 18th Annual Needham Healthcare Conference in New York City.

Arcadia Biosciences, Inc. (Nasdaq: RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today released its financial and business results for the fourth quarter and full year of 2018.

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), Neuren Pharmaceuticals Limited (ASX: NEU), and Rettsyndrome.org (RSO) announced today that the positive results from a Phase 2 study conducted by Neuren, which evaluated the safety and efficacy of trofinetide in females with Rett syndrome (RTT), have been published in Neurology®, the medical journal of the American Academy of Neurology.

CVD Equipment Corporation (NASDAQ: CVV), a leading provider of chemical vapor deposition systems, announced today that it will release its 2018 fourth quarter and annual financial results after markets close on Monday, April 1, 2019.

Sunniva Inc. (“Sunniva”, the “Company”, “we”, “our” or “us”) (CSE: SNN) (OTCQB: SNNVF), reports that it has been named in a class action lawsuit, along with its wholly owned subsidiary, Natural Health Services Ltd. (“NHS”), in connection with a privacy breach of the Electronic Medical Record (“EMR”) system used by NHS.

Tricida, Inc. announced that it will report results from its blinded, 40-week extension trial, TRCA-301E, tomorrow morning at 7:15 am Eastern Time.